DK2420570T3 - Arabinofuranosidaseenzymer, nucleinsyrer, som koder for dem, og fremgangsmåder til at fremstille og anvende dem - Google Patents
Arabinofuranosidaseenzymer, nucleinsyrer, som koder for dem, og fremgangsmåder til at fremstille og anvende dem Download PDFInfo
- Publication number
- DK2420570T3 DK2420570T3 DK11007477T DK11007477T DK2420570T3 DK 2420570 T3 DK2420570 T3 DK 2420570T3 DK 11007477 T DK11007477 T DK 11007477T DK 11007477 T DK11007477 T DK 11007477T DK 2420570 T3 DK2420570 T3 DK 2420570T3
- Authority
- DK
- Denmark
- Prior art keywords
- polypeptide
- nucleic acid
- sequence
- seq
- optionally
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims description 372
- 102000039446 nucleic acids Human genes 0.000 title claims description 304
- 108020004707 nucleic acids Proteins 0.000 title claims description 304
- 238000000034 method Methods 0.000 title claims description 193
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 382
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 366
- 229920001184 polypeptide Polymers 0.000 claims description 357
- 108090000790 Enzymes Proteins 0.000 claims description 311
- 102000004190 Enzymes Human genes 0.000 claims description 310
- 229940088598 enzyme Drugs 0.000 claims description 310
- 108010059892 Cellulase Proteins 0.000 claims description 186
- 210000004027 cell Anatomy 0.000 claims description 170
- 230000000694 effects Effects 0.000 claims description 144
- 241000196324 Embryophyta Species 0.000 claims description 142
- 239000000203 mixture Substances 0.000 claims description 135
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 claims description 129
- 108090000623 proteins and genes Proteins 0.000 claims description 119
- -1 or a non-oligomerase Proteins 0.000 claims description 109
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 92
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 92
- 239000013598 vector Substances 0.000 claims description 87
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 86
- 229940106157 cellulase Drugs 0.000 claims description 86
- 230000014509 gene expression Effects 0.000 claims description 76
- 239000000047 product Substances 0.000 claims description 72
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 71
- 229920002678 cellulose Polymers 0.000 claims description 67
- 239000001913 cellulose Substances 0.000 claims description 67
- 108010038658 exo-1,4-beta-D-xylosidase Proteins 0.000 claims description 62
- 239000000123 paper Substances 0.000 claims description 62
- 238000002703 mutagenesis Methods 0.000 claims description 57
- 231100000350 mutagenesis Toxicity 0.000 claims description 57
- 240000008042 Zea mays Species 0.000 claims description 55
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 55
- 239000002028 Biomass Substances 0.000 claims description 54
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 46
- 235000005822 corn Nutrition 0.000 claims description 46
- 239000000463 material Substances 0.000 claims description 44
- 108020004705 Codon Proteins 0.000 claims description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 238000004519 manufacturing process Methods 0.000 claims description 42
- 239000002773 nucleotide Substances 0.000 claims description 42
- 125000003729 nucleotide group Chemical group 0.000 claims description 42
- 238000004422 calculation algorithm Methods 0.000 claims description 35
- 230000008569 process Effects 0.000 claims description 33
- 108020004414 DNA Proteins 0.000 claims description 32
- 239000002023 wood Substances 0.000 claims description 30
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 28
- 235000013305 food Nutrition 0.000 claims description 28
- 210000001519 tissue Anatomy 0.000 claims description 28
- 150000001413 amino acids Chemical class 0.000 claims description 25
- 239000013612 plasmid Substances 0.000 claims description 24
- 241001465754 Metazoa Species 0.000 claims description 22
- 230000001580 bacterial effect Effects 0.000 claims description 20
- 239000010893 paper waste Substances 0.000 claims description 20
- 230000003197 catalytic effect Effects 0.000 claims description 19
- 235000000346 sugar Nutrition 0.000 claims description 19
- 229920002488 Hemicellulose Polymers 0.000 claims description 18
- 230000027455 binding Effects 0.000 claims description 18
- 238000010367 cloning Methods 0.000 claims description 18
- 230000000051 modifying effect Effects 0.000 claims description 18
- 238000012545 processing Methods 0.000 claims description 17
- 239000000446 fuel Substances 0.000 claims description 16
- 230000009261 transgenic effect Effects 0.000 claims description 16
- 239000002699 waste material Substances 0.000 claims description 16
- 238000004458 analytical method Methods 0.000 claims description 15
- 235000015872 dietary supplement Nutrition 0.000 claims description 15
- 108010038196 saccharide-binding proteins Proteins 0.000 claims description 15
- 229920001131 Pulp (paper) Polymers 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 13
- 241000238631 Hexapoda Species 0.000 claims description 12
- 230000000295 complement effect Effects 0.000 claims description 12
- 235000010469 Glycine max Nutrition 0.000 claims description 11
- 244000068988 Glycine max Species 0.000 claims description 11
- 244000061456 Solanum tuberosum Species 0.000 claims description 11
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 10
- 235000021307 Triticum Nutrition 0.000 claims description 10
- 239000006227 byproduct Substances 0.000 claims description 10
- 238000012217 deletion Methods 0.000 claims description 10
- 230000037430 deletion Effects 0.000 claims description 10
- 238000002741 site-directed mutagenesis Methods 0.000 claims description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 9
- 238000011179 visual inspection Methods 0.000 claims description 9
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 8
- 235000013365 dairy product Nutrition 0.000 claims description 8
- 230000002538 fungal effect Effects 0.000 claims description 8
- 210000004962 mammalian cell Anatomy 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 235000007164 Oryza sativa Nutrition 0.000 claims description 7
- 210000004436 artificial bacterial chromosome Anatomy 0.000 claims description 7
- 239000011111 cardboard Substances 0.000 claims description 7
- 230000003301 hydrolyzing effect Effects 0.000 claims description 7
- 239000005022 packaging material Substances 0.000 claims description 7
- 229920000642 polymer Polymers 0.000 claims description 7
- 235000009566 rice Nutrition 0.000 claims description 7
- 241000701161 unidentified adenovirus Species 0.000 claims description 7
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 6
- 241000335053 Beta vulgaris Species 0.000 claims description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 6
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 claims description 6
- 210000001106 artificial yeast chromosome Anatomy 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229920005610 lignin Polymers 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 6
- 239000004753 textile Substances 0.000 claims description 6
- 239000013603 viral vector Substances 0.000 claims description 6
- 210000005253 yeast cell Anatomy 0.000 claims description 6
- 238000007792 addition Methods 0.000 claims description 5
- 238000001727 in vivo Methods 0.000 claims description 5
- 230000004048 modification Effects 0.000 claims description 5
- 238000012986 modification Methods 0.000 claims description 5
- 230000006798 recombination Effects 0.000 claims description 5
- 238000005215 recombination Methods 0.000 claims description 5
- 230000001131 transforming effect Effects 0.000 claims description 5
- 229920000617 arabinoxylan Polymers 0.000 claims description 4
- 210000004507 artificial chromosome Anatomy 0.000 claims description 4
- 235000008429 bread Nutrition 0.000 claims description 4
- 238000012219 cassette mutagenesis Methods 0.000 claims description 4
- 230000001461 cytolytic effect Effects 0.000 claims description 4
- 239000000835 fiber Substances 0.000 claims description 4
- 230000008439 repair process Effects 0.000 claims description 4
- 230000001177 retroviral effect Effects 0.000 claims description 4
- 230000001568 sexual effect Effects 0.000 claims description 4
- 230000002950 deficient Effects 0.000 claims description 3
- 239000000645 desinfectant Substances 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- 230000002163 immunogen Effects 0.000 claims description 3
- 239000012978 lignocellulosic material Substances 0.000 claims description 3
- 241001515965 unidentified phage Species 0.000 claims description 3
- 229940035893 uracil Drugs 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 108700010070 Codon Usage Proteins 0.000 claims description 2
- 241000702191 Escherichia virus P1 Species 0.000 claims description 2
- 240000000111 Saccharum officinarum Species 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 235000012015 potatoes Nutrition 0.000 claims description 2
- 238000011282 treatment Methods 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 239000004463 hay Substances 0.000 claims 3
- 239000000882 contact lens solution Substances 0.000 claims 2
- 210000000415 mammalian chromosome Anatomy 0.000 claims 2
- 240000005979 Hordeum vulgare Species 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 229940127240 opiate Drugs 0.000 claims 1
- 238000011176 pooling Methods 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 description 54
- 102000004169 proteins and genes Human genes 0.000 description 51
- 235000018102 proteins Nutrition 0.000 description 48
- 239000012634 fragment Substances 0.000 description 47
- 239000000758 substrate Substances 0.000 description 46
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 43
- 239000000523 sample Substances 0.000 description 40
- 230000003321 amplification Effects 0.000 description 38
- 238000003199 nucleic acid amplification method Methods 0.000 description 38
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 34
- 239000008103 glucose Substances 0.000 description 33
- 102000040430 polynucleotide Human genes 0.000 description 32
- 108091033319 polynucleotide Proteins 0.000 description 32
- 239000002157 polynucleotide Substances 0.000 description 32
- 239000007787 solid Substances 0.000 description 31
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 30
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 30
- 239000013615 primer Substances 0.000 description 27
- 239000013604 expression vector Substances 0.000 description 26
- 238000012360 testing method Methods 0.000 description 26
- 235000001014 amino acid Nutrition 0.000 description 25
- 229940024606 amino acid Drugs 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 24
- 238000004590 computer program Methods 0.000 description 24
- 238000003752 polymerase chain reaction Methods 0.000 description 22
- 108091034117 Oligonucleotide Proteins 0.000 description 20
- 238000013518 transcription Methods 0.000 description 20
- 230000035897 transcription Effects 0.000 description 20
- 150000001875 compounds Chemical class 0.000 description 19
- 230000007423 decrease Effects 0.000 description 19
- 235000013339 cereals Nutrition 0.000 description 18
- 239000003623 enhancer Substances 0.000 description 18
- 108091026890 Coding region Proteins 0.000 description 17
- 230000029087 digestion Effects 0.000 description 17
- 239000002609 medium Substances 0.000 description 16
- 238000013500 data storage Methods 0.000 description 15
- 150000003384 small molecules Chemical class 0.000 description 15
- 230000007613 environmental effect Effects 0.000 description 14
- 239000011159 matrix material Substances 0.000 description 14
- 238000000746 purification Methods 0.000 description 14
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 14
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 13
- 230000014616 translation Effects 0.000 description 13
- 238000013519 translation Methods 0.000 description 13
- 102000005575 Cellulases Human genes 0.000 description 12
- 108010084185 Cellulases Proteins 0.000 description 12
- 238000003556 assay Methods 0.000 description 12
- 239000007795 chemical reaction product Substances 0.000 description 12
- 238000006460 hydrolysis reaction Methods 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 241000700605 Viruses Species 0.000 description 11
- 230000001939 inductive effect Effects 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 239000010907 stover Substances 0.000 description 11
- 241000209504 Poaceae Species 0.000 description 10
- 241000209140 Triticum Species 0.000 description 10
- 238000004113 cell culture Methods 0.000 description 10
- 210000003527 eukaryotic cell Anatomy 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- 230000007062 hydrolysis Effects 0.000 description 10
- 230000001105 regulatory effect Effects 0.000 description 10
- 241000588724 Escherichia coli Species 0.000 description 9
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 9
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 9
- 238000010586 diagram Methods 0.000 description 9
- 230000002068 genetic effect Effects 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 235000009973 maize Nutrition 0.000 description 9
- 239000008188 pellet Substances 0.000 description 9
- 238000012384 transportation and delivery Methods 0.000 description 9
- 239000003981 vehicle Substances 0.000 description 9
- 229920001503 Glucan Polymers 0.000 description 8
- 241000209219 Hordeum Species 0.000 description 8
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 8
- 241000209094 Oryza Species 0.000 description 8
- 241001520808 Panicum virgatum Species 0.000 description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 8
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 8
- 108020001507 fusion proteins Proteins 0.000 description 8
- 102000037865 fusion proteins Human genes 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 229920001542 oligosaccharide Polymers 0.000 description 8
- 238000005453 pelletization Methods 0.000 description 8
- 150000008163 sugars Chemical class 0.000 description 8
- 229920002498 Beta-glucan Polymers 0.000 description 7
- 241000849740 Gadidae environmental sample Species 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 230000002759 chromosomal effect Effects 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 239000004009 herbicide Substances 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 230000002103 transcriptional effect Effects 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 241000701489 Cauliflower mosaic virus Species 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 241001327268 Sorghastrum Species 0.000 description 6
- 238000005571 anion exchange chromatography Methods 0.000 description 6
- 230000000692 anti-sense effect Effects 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 230000018109 developmental process Effects 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 239000000178 monomer Substances 0.000 description 6
- 230000008488 polyadenylation Effects 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 150000004804 polysaccharides Chemical class 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 238000001890 transfection Methods 0.000 description 6
- 230000003612 virological effect Effects 0.000 description 6
- 244000075850 Avena orientalis Species 0.000 description 5
- 235000007319 Avena orientalis Nutrition 0.000 description 5
- 240000002791 Brassica napus Species 0.000 description 5
- 241000228437 Cochliobolus Species 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 102000004157 Hydrolases Human genes 0.000 description 5
- 108090000604 Hydrolases Proteins 0.000 description 5
- 241000227653 Lycopersicon Species 0.000 description 5
- 229930193140 Neomycin Natural products 0.000 description 5
- 108020004459 Small interfering RNA Proteins 0.000 description 5
- 239000004098 Tetracycline Substances 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 230000002210 biocatalytic effect Effects 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 230000001186 cumulative effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000002363 herbicidal effect Effects 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 229960004927 neomycin Drugs 0.000 description 5
- 150000002482 oligosaccharides Chemical class 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000010076 replication Effects 0.000 description 5
- 229960002180 tetracycline Drugs 0.000 description 5
- 229930101283 tetracycline Natural products 0.000 description 5
- 235000019364 tetracycline Nutrition 0.000 description 5
- 150000003522 tetracyclines Chemical class 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 229930192334 Auxin Natural products 0.000 description 4
- 102100032487 Beta-mannosidase Human genes 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 4
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 4
- 108091092195 Intron Proteins 0.000 description 4
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 4
- 241000208125 Nicotiana Species 0.000 description 4
- 244000061176 Nicotiana tabacum Species 0.000 description 4
- 108091093037 Peptide nucleic acid Proteins 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 108020005091 Replication Origin Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 108010022394 Threonine synthase Proteins 0.000 description 4
- 102000006601 Thymidine Kinase Human genes 0.000 description 4
- 108020004440 Thymidine kinase Proteins 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 239000000074 antisense oligonucleotide Substances 0.000 description 4
- 238000012230 antisense oligonucleotides Methods 0.000 description 4
- 239000002363 auxin Substances 0.000 description 4
- 108010055059 beta-Mannosidase Proteins 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000005251 capillar electrophoresis Methods 0.000 description 4
- 238000005277 cation exchange chromatography Methods 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 102000004419 dihydrofolate reductase Human genes 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000004520 electroporation Methods 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 210000001035 gastrointestinal tract Anatomy 0.000 description 4
- 239000010903 husk Substances 0.000 description 4
- 238000000338 in vitro Methods 0.000 description 4
- 101150066555 lacZ gene Proteins 0.000 description 4
- 210000000723 mammalian artificial chromosome Anatomy 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 210000001236 prokaryotic cell Anatomy 0.000 description 4
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 4
- 239000010902 straw Substances 0.000 description 4
- 229960004793 sucrose Drugs 0.000 description 4
- 241001430294 unidentified retrovirus Species 0.000 description 4
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 3
- 208000023514 Barrett esophagus Diseases 0.000 description 3
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 3
- 230000004544 DNA amplification Effects 0.000 description 3
- 102100029727 Enteropeptidase Human genes 0.000 description 3
- 108010013369 Enteropeptidase Proteins 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 3
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- 241000282849 Ruminantia Species 0.000 description 3
- 206010046865 Vaccinia virus infection Diseases 0.000 description 3
- 108020005202 Viral DNA Proteins 0.000 description 3
- 208000036142 Viral infection Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 210000004102 animal cell Anatomy 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000007845 assembly PCR Methods 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 125000001547 cellobiose group Chemical group 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229960005091 chloramphenicol Drugs 0.000 description 3
- 201000004065 complex cortical dysplasia with other brain malformations 3 Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 125000003147 glycosyl group Chemical group 0.000 description 3
- 230000013595 glycosylation Effects 0.000 description 3
- 238000006206 glycosylation reaction Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000001638 lipofection Methods 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 108091070501 miRNA Proteins 0.000 description 3
- 239000002679 microRNA Substances 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000002853 nucleic acid probe Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 102000054765 polymorphisms of proteins Human genes 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000009305 pseudorabies Diseases 0.000 description 3
- 229960004889 salicylic acid Drugs 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 239000002924 silencing RNA Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 241000701447 unidentified baculovirus Species 0.000 description 3
- 208000007089 vaccinia Diseases 0.000 description 3
- 230000009385 viral infection Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- LGQKSQQRKHFMLI-SJYYZXOBSA-N (2s,3r,4s,5r)-2-[(3r,4r,5r,6r)-4,5,6-trihydroxyoxan-3-yl]oxyoxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)CO[C@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)OC1 LGQKSQQRKHFMLI-SJYYZXOBSA-N 0.000 description 2
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 2
- OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 2
- LGQKSQQRKHFMLI-UHFFFAOYSA-N 4-O-beta-D-xylopyranosyl-beta-D-xylopyranose Natural products OC1C(O)C(O)COC1OC1C(O)C(O)C(O)OC1 LGQKSQQRKHFMLI-UHFFFAOYSA-N 0.000 description 2
- 108010051457 Acid Phosphatase Proteins 0.000 description 2
- 102000013563 Acid Phosphatase Human genes 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- 241000219194 Arabidopsis Species 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 2
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 241001515826 Cassava vein mosaic virus Species 0.000 description 2
- 108091062157 Cis-regulatory element Proteins 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SQNRKWHRVIAKLP-UHFFFAOYSA-N D-xylobiose Natural products O=CC(O)C(O)C(CO)OC1OCC(O)C(O)C1O SQNRKWHRVIAKLP-UHFFFAOYSA-N 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 101710098246 Exoglucanase 2 Proteins 0.000 description 2
- 108700024394 Exon Proteins 0.000 description 2
- 241000700662 Fowlpox virus Species 0.000 description 2
- 101000798222 Homo sapiens Antizyme inhibitor 2 Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- 108090001090 Lectins Proteins 0.000 description 2
- 102000004856 Lectins Human genes 0.000 description 2
- 241000219823 Medicago Species 0.000 description 2
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 241000209117 Panicum Species 0.000 description 2
- 108010066717 Q beta Replicase Proteins 0.000 description 2
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 2
- 230000006819 RNA synthesis Effects 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 108091027981 Response element Proteins 0.000 description 2
- 241000701507 Rice tungro bacilliform virus Species 0.000 description 2
- 241001327284 Sorghastrum nutans Species 0.000 description 2
- 241000256248 Spodoptera Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021536 Sugar beet Nutrition 0.000 description 2
- 108700005078 Synthetic Genes Proteins 0.000 description 2
- 101150006914 TRP1 gene Proteins 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 241000499912 Trichoderma reesei Species 0.000 description 2
- 108010027199 Xylosidases Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000010828 animal waste Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 238000002869 basic local alignment search tool Methods 0.000 description 2
- OCIBBXPLUVYKCH-FYTDUCIRSA-N beta-D-cellohexaose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3[C@H](O[C@@H](O[C@@H]4[C@H](O[C@@H](O[C@@H]5[C@H](O[C@@H](O)[C@H](O)[C@H]5O)CO)[C@H](O)[C@H]4O)CO)[C@H](O)[C@H]3O)CO)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O OCIBBXPLUVYKCH-FYTDUCIRSA-N 0.000 description 2
- AFYNADDZULBEJA-UHFFFAOYSA-N bicinchoninic acid Chemical compound C1=CC=CC2=NC(C=3C=C(C4=CC=CC=C4N=3)C(=O)O)=CC(C(O)=O)=C21 AFYNADDZULBEJA-UHFFFAOYSA-N 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 230000001851 biosynthetic effect Effects 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- OCIBBXPLUVYKCH-UHFFFAOYSA-N cellopentanose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(OC3C(OC(OC4C(OC(OC5C(OC(O)C(O)C5O)CO)C(O)C4O)CO)C(O)C3O)CO)C(O)C2O)CO)C(O)C1O OCIBBXPLUVYKCH-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000012459 cleaning agent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 238000012411 cloning technique Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 235000014510 cooky Nutrition 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 229940079919 digestives enzyme preparation Drugs 0.000 description 2
- 230000006862 enzymatic digestion Effects 0.000 description 2
- 238000012869 ethanol precipitation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 230000004345 fruit ripening Effects 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 230000009368 gene silencing by RNA Effects 0.000 description 2
- 230000002414 glycolytic effect Effects 0.000 description 2
- 108010002430 hemicellulase Proteins 0.000 description 2
- 239000000833 heterodimer Substances 0.000 description 2
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 2
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 2
- 238000012872 hydroxylapatite chromatography Methods 0.000 description 2
- 210000001822 immobilized cell Anatomy 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000002523 lectin Substances 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- 239000002029 lignocellulosic biomass Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000033607 mismatch repair Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 231100000219 mutagenic Toxicity 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229940080469 phosphocellulose Drugs 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000030788 protein refolding Effects 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 210000001995 reticulocyte Anatomy 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000005026 transcription initiation Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 229920001221 xylan Polymers 0.000 description 2
- 150000004823 xylans Chemical class 0.000 description 2
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- IRLPACMLTUPBCL-KQYNXXCUSA-N 5'-adenylyl sulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OS(O)(=O)=O)[C@@H](O)[C@H]1O IRLPACMLTUPBCL-KQYNXXCUSA-N 0.000 description 1
- 101000818108 Acholeplasma phage L2 Uncharacterized 81.3 kDa protein Proteins 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 108700007757 Arabidopsis GSTF8 Proteins 0.000 description 1
- 108700040922 Arabidopsis LFY Proteins 0.000 description 1
- 101100215339 Arabidopsis thaliana ACT11 gene Proteins 0.000 description 1
- 101100238293 Arabidopsis thaliana MOR1 gene Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 101150077012 BEL1 gene Proteins 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000702286 Bean golden mosaic virus Species 0.000 description 1
- 241000228438 Bipolaris maydis Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 108091033380 Coding strand Proteins 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 101000866354 Cryptopygus antarcticus Glucan endo-1,3-beta-glucosidase Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 241001057636 Dracaena deremensis Species 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 101710112457 Exoglucanase Proteins 0.000 description 1
- 101710098247 Exoglucanase 1 Proteins 0.000 description 1
- 108010074860 Factor Xa Proteins 0.000 description 1
- 101150030514 GPC1 gene Proteins 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 240000002024 Gossypium herbaceum Species 0.000 description 1
- 235000004341 Gossypium herbaceum Nutrition 0.000 description 1
- 101150094780 Gpc2 gene Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 101000912350 Haemophilus phage HP1 (strain HP1c1) DNA N-6-adenine-methyltransferase Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000735376 Homo sapiens Protocadherin-8 Proteins 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 101000790844 Klebsiella pneumoniae Uncharacterized 24.8 kDa protein in cps region Proteins 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920002097 Lichenin Polymers 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101000763602 Manilkara zapota Thaumatin-like protein 1 Proteins 0.000 description 1
- 101000763586 Manilkara zapota Thaumatin-like protein 1a Proteins 0.000 description 1
- 241001599018 Melanogaster Species 0.000 description 1
- 241000203407 Methanocaldococcus jannaschii Species 0.000 description 1
- 244000202563 Meum athamanticum Species 0.000 description 1
- 108010093369 Multienzyme Complexes Proteins 0.000 description 1
- 102000002568 Multienzyme Complexes Human genes 0.000 description 1
- 101100217138 Mus musculus Actr10 gene Proteins 0.000 description 1
- 101000969137 Mus musculus Metallothionein-1 Proteins 0.000 description 1
- 101000966653 Musa acuminata Glucan endo-1,3-beta-glucosidase Proteins 0.000 description 1
- 241000204051 Mycoplasma genitalium Species 0.000 description 1
- 230000004988 N-glycosylation Effects 0.000 description 1
- 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 235000011464 Pachycereus pringlei Nutrition 0.000 description 1
- 235000011466 Pachycereus weberi Nutrition 0.000 description 1
- 240000006939 Pachycereus weberi Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000219843 Pisum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 108091036407 Polyadenylation Proteins 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- 208000020584 Polyploidy Diseases 0.000 description 1
- 241000709992 Potato virus X Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100034958 Protocadherin-8 Human genes 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 102000004389 Ribonucleoproteins Human genes 0.000 description 1
- 108010081734 Ribonucleoproteins Proteins 0.000 description 1
- 241000193448 Ruminiclostridium thermocellum Species 0.000 description 1
- 101150012041 SK2 gene Proteins 0.000 description 1
- 101150090744 SPL3 gene Proteins 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 101150019148 Slc7a3 gene Proteins 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- 108091027544 Subgenomic mRNA Proteins 0.000 description 1
- 206010042602 Supraventricular extrasystoles Diseases 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 241000203780 Thermobifida fusca Species 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 241000723792 Tobacco etch virus Species 0.000 description 1
- 241000723873 Tobacco mosaic virus Species 0.000 description 1
- 241000723848 Tobamovirus Species 0.000 description 1
- 241000710145 Tomato bushy stunt virus Species 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108020004566 Transfer RNA Proteins 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 1
- 229920002000 Xyloglucan Polymers 0.000 description 1
- 230000006578 abscission Effects 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 108010093941 acetylxylan esterase Proteins 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 108010036419 acyl-(acyl-carrier-protein)desaturase Proteins 0.000 description 1
- 230000002730 additional effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 239000002154 agricultural waste Substances 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- WQZGKKKJIJFFOK-UHFFFAOYSA-N alpha-D-glucopyranose Natural products OCC1OC(O)C(O)C(O)C1O WQZGKKKJIJFFOK-UHFFFAOYSA-N 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 235000012180 bread and bread product Nutrition 0.000 description 1
- 238000013124 brewing process Methods 0.000 description 1
- 235000010633 broth Nutrition 0.000 description 1
- 101150039352 can gene Proteins 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 108010052085 cellobiose-quinone oxidoreductase Proteins 0.000 description 1
- 108010080434 cephalosporin-C deacetylase Proteins 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 230000002153 concerted effect Effects 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000012866 crystallographic experiment Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 108010091371 endoglucanase 1 Proteins 0.000 description 1
- 108010091384 endoglucanase 2 Proteins 0.000 description 1
- 108010092450 endoglucanase Z Proteins 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- 108010093305 exopolygalacturonase Proteins 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 108010041969 feruloyl esterase Proteins 0.000 description 1
- 235000021197 fiber intake Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000028245 fruit abscission Effects 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 101150056310 gem1 gene Proteins 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 102000005396 glutamine synthetase Human genes 0.000 description 1
- 108020002326 glutamine synthetase Proteins 0.000 description 1
- 230000001279 glycosylating effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 210000000688 human artificial chromosome Anatomy 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 238000012994 industrial processing Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000010808 liquid waste Substances 0.000 description 1
- 238000002865 local sequence alignment Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 210000000473 mesophyll cell Anatomy 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000001724 microfibril Anatomy 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- ZAHQPTJLOCWVPG-UHFFFAOYSA-N mitoxantrone dihydrochloride Chemical compound Cl.Cl.O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO ZAHQPTJLOCWVPG-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- HFHZKZSRXITVMK-UHFFFAOYSA-N oxyphenbutazone Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=C(O)C=C1 HFHZKZSRXITVMK-UHFFFAOYSA-N 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical group 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 239000010908 plant waste Substances 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000004055 small Interfering RNA Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002910 solid waste Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/248—Xylanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01004—Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01006—Endo-1,3(4)-beta-glucanase (3.2.1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01008—Endo-1,4-beta-xylanase (3.2.1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01021—Beta-glucosidase (3.2.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01039—Glucan endo-1,3-beta-D-glucosidase (3.2.1.39)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01055—Alpha-N-arabinofuranosidase (3.2.1.55)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01091—Cellulose 1,4-beta-cellobiosidase (3.2.1.91)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/249921—Web or sheet containing structurally defined element or component
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Fodder In General (AREA)
- Peptides Or Proteins (AREA)
Claims (19)
1. Isoleret, syntetisk eller rekombinant nucleinsyre omfattende (a) en nucleinsyresekvens med mindst 70% 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% eller mere eller komplet (100%) sekvensidentitet til SEQ ID NO: 103, hvor nucleinsy-ren, som koder for et polypeptid, har en arabinofuranosidaseaktivitet, og eventuelt er sekvensidentiteterne bestemt ved analyse med en sekvenssammenligningsalgoritme eller ved en visuel inspicering, eller (b) en nucleinsyresekvens, som hybridiserer ved stringente betingelser til en nucleinsyre omfattende SEQ ID NO: 103, hvor nucleinsyren koder for et polypeptid med en arabinofuranosidaseaktivitet, og har mindst 70% identitet med SEQ ID NO: 103, og de stringente betingelser indbefatter et vasketrin omfattende en vask med 0,2 X SSC ved en temperatur på ca. 65°C i ca. 15 minutter, (c) en nucleinsyresekvens, som koder for et polypeptid med mindst 70% identitet med sekvensen i SEQ ID NO: 104, hvor polypeptidet har arabinofuranosidaseaktivitet, (d) nucleinsyren i (a), (b) eller (c), som koder for et polypeptid med en arabinofuranosidaseaktivitet, men mangler en signalsekvens eller et carbohy-dratbindingsmodul, (e) nucleinsyren i (a), (b), (c) eller (d), som koder for et polypeptid med en arabinofuranosidaseaktivitet, men har en heterolog sekvens, hvor den heterologe sekvens eventuelt omfatter en heterolog signalsekvens, et carbohydratbindingsmodul, et katalytisk domæne (CD) eller en kombination heraf, og eventuelt den heterologe signalsekvens, carbohy-dratbindingsmodulet eller det katalytiske domæne (CD) er afledt fra en anden oligomerase, cellulase eller cellulytisk enzym, eller en non-oligomera-se, -cellulase eller -cellulytisk enzym, eller (f) en nucleinsyresekvens fuldstændig komplementær til (a), (b), (c), (d) eller (e).
2. Ekspressionskassette, vektor eller kloningsvehikel omfattende en nuclein-syre omfattende sekvensen i krav 1, hvor eventuelt kloningsvehiklen omfatter en viral vektor, et plasmid, en phag, et phagemid, et cosmid, et fosmid, en bak-teriophag eller et kunstigt kromosom, og hvor eventuelt kloningsvehiklen omfatter en viral vektor omfattende en adenovirusvektor, en retroviral vektor eller en adenoassocieret viral vektor, eller hvor eventuelt kloningsvehiklen omfatter et bakterielt kunstigt kromosom (BAC), et plasmid, en bakteriophag P1-afledt vektor (PAC), et kunstigt gærkromosom (YAC) eller et kunstigt patterdyrskromosom (MAC).
3. Transformeret celle omfattende en nucleinsyre omfattende sekvensen i krav 1, eller en vektor eller kloningsvehikel som anført i krav 2, hvor eventuelt cellen er en bakteriel celle, en pattedyrscelle, en svampecelle, en gærcelle, en insektcelle eller en plantecelle, og hvor den transformerede celle producerer et polypeptid kodet for af nucleinsyren ifølge krav 1, og som har arabinofurano-sidaseaktivitet.
4. Transgent ikke-humant dyr, plante, plantedel eller plantefrø omfattende sekvensen i krav 1 eller en vektor eller kloningsvehikel ifølge krav 2, hvor eventuelt det transgene ikke-humane dyr er en mus eller en rotte, og hvor det ikke-humane dyrs, plantes, plantedels eller plantefrøs transformerede celle fremstiller et polypeptid kodet for af nucleinsyren i krav 1, og har arabinofuranosidase-aktivitet.
5. Isoleret, syntetisk eller rekombinant polypeptid (i) med en aminosyresekvens, som har mindst 70%, 71 %, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81 %, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% eller mere eller 100% sekvensidentitet til SEQ ID NO: 104, hvor polypepti-det har en arabinofuranosidaseaktivitet, hvor sekvensidentiteterne eventuelt bestemmes ved analyse med en sekvenssammenligningsalgoritme eller ved visuel inspektion, og eventuelt er sekvenssammenligningsalgoritmen en BLAST version 2.2.2-algoritme, hvor en filtreringsindstilling er sat til blastall-p blastp -d, ”nr pataa”-F F, og alle andre valg er sat til default, (ii) med en aminosyresekvens kodet for af en nucleinsyre ifølge krav 1, hvor polypeptidet har en arabinofuranosidaseaktivitet eller har immunogen aktivitet derved, at den er i stand til at generere et antistof, som specifikt binder til et polypeptid med sekvensen i SEQ ID NO: 104, (iii) polypeptidet i (i) eller (ii) med en arabinofuranosidaseaktivitet, men uden en signalsekvens, (iv) polypeptidet fra (i), (ii) eller (iii) med en arabinofuranosidaseaktivitet, men som har en heterolog sekvens, hvor den heterologe sekvens ifølge krav omfatter en heterolog signalsekvens, et carbohydratbindingsmodul, et katalytisk domæne (CD) eller en kombination heraf, og den heterologe signalsekvens, carbohydratbindings-modulet eller det katalytiske domæne (CD) stammer eventuelt fra en anden oligomerase, cellulase eller cellulytisk enzym, eller en non-oligomera-se, -cellulase eller non-cellulytisk enzym, eller (v) polypeptidet fra (i), (ii), (iii) eller (iv), hvor polypeptidet er glycosyleret.
6. Isoleret, syntetisk eller rekombinant polypeptid med en aminosyresekvens fra SEQ ID NO: 104.
7. Polypeptid ifølge krav 6 med arabinofuranosidaseaktivitet, en signalsekvens og et carbohydratbindingsmodul.
8. Fremgangsmåde til fremstilling af et rekombinant polypeptid omfattende trinnene: (a) tilvejebringelse af en nucleinsyre ifølge krav 1, og (b) ekspression af nucleinsyren i trin (a) ved betingelser, som tillader ekspression af polypeptidet, og derved producere et rekombinant polypeptid, hvor eventuelt fremgangsmåden yderligere omfatter at transformere en værtscelle med nucleinsyren fra trin (a) fulgt at ekspression af nucleinsyren fra trin (a) og derved producere et rekombinant polypeptid i en transformeret celle.
9. Fremgangsmåde til at generere en variant af en nucleinsyre, som koder for et polypeptid med en arabinofuranosidaseaktivitet omfattende trinnene: (a) tilvejebringelse af en templatnucleinsyre omfattende sekvensen ifølge krav 1, og (b) modificering, deletering eller addering af en eller flere nucleotider i tem-platsekvensen, eller en kombination heraf for at generere en variant af templatnucleinsyren, hvor fremgangsmåden eventuelt omfatter at udtrykke nucleinsyrevarianten for at generere en oligomerasevariant og/eller cellulasepolypeptidvariant, og eventuelt indføres modifikationerne, additionerne eller deleteringerne ved en fremgangsmåde omfattende fejlbehæftet PCR, shuffling, oligonucleotidrettet mutagenese, samlings-PCR, seksuel PCR-mutagenese, in vivo mutagenese, kassettemutagenese, rekursiv gruppemutagenese, eksponentiel gruppemutage-nese, stedsspecifik mutagenese, gensamling, Gene Site Saturation Mutagenesis (GSSM), syntetisk ligeringsgensamling (SLR), rekombination, rekursiv sekvensrekombination, phosphothiat-modificeret DNA mutagenese, uracilholdig templatmutagenese, gapped dupleks mutagenese, punktfejlparringsreparations-mutagenese, reparationsdeficient værtsstammemutagenese, kemisk mutagenese, radiogenisk mutagenese, deleteringsmutagenese, restriktions/selekterings-mutagenese, restriktionsoprensningsmutagenese, kunstig gensyntese, homo-mutagenese, kimærisk nucleinsyre multimerskabelse og en kombination heraf, og hvor fremgangsmåden eventuelt iterativt gentages indtil en oligomerase og/-eller en cellulase med en ændret eller forskellig aktivitet, en ændret eller forskellig stabilitet, en ændret kodonanvendelse eller en højere eller lavere grad af messageekspressioner sammenlignet med et polypeptid kodet af templatnucleinsyren fremstilles.
10. Fremgangsmåde til at modificere kodoner i en nucleinsyrer, som koder for et arabinofuranosidasepolypeptid, hvilken fremgangsmåde omfatter følgende trin: (a) tilvejebringelse af en nucleinsyre, som koder for et polypeptid ifølge krav 5, og (b) identificering af en kodon i nucleinsyren i trin (a) og erstatning af den med en forskellig kodon, som koder for den samme aminosyre som den erstattede kodon og derved modificerer kodoner i en nucleinsyre, som koder for en cellulase.
11. Kimærisk polypeptid omfattende et første domæne og mindst et andet domæne, hvor det første domæne omfatter et enzym som anført i krav 5, og det andet domæne omfatter et heterologt eller modificeret carbohydratbindingsdo-mæne eller et heterologt eller modificeret dockerin-domæne, og carbohydratbin-dingsdomænet eventuelt er et cellulosebindende modul (CBM), eller et lignin-bindende domæne, og det andet domæne eventuelt vedhæftet tæt ved enzymets katalytiske domæne, og det andet domæne er eventuelt hæftet omtrent ved C-terminalen af enzymets katalytiske domæne.
12. Sammensætning eller fremstillingsprodukt omfattende (a) en blanding (eller ’’cocktail”) af hemicellulose- og cellulose-hydrolyse-rende enzymer, hvor de cellulosehydrolyserende enzymer omfatter mindst et af hver af en endoglucanase, cellobiohydrolase I (CBHI), cellobiohydro-lase 11 (CBH11) og β-glucosidase, og de hemicellulosehydrolyserende enzymer omfatter mindst et af hver af en xylanase, β- xylosidase og arabino-furanosidase, hvor mindst en arabinofuranosidase er et polypeptid ifølge krav 5 eller et polypeptid kodet for af en nucleinsyre ifølge krav 1, (b) en blanding (eller ’’cocktail”) af hemicellulose- og cellulosehydrolyserende enzymer omfattende mindst et af hver af en endoglucanase, oligomera-se, cellobiohydrolase I (CBHI), cellobiohydrolase II (CBHII), arabinofuranosidase og xylanase, hvor oligomerasen eventuelt er en oligomerase-1 eller β-g lu cos id ase eller oligomerasen eventuelt er en oligomerase-2 eller β-xy-losidase, og hvor mindst en arabinofuranosidase er et polypeptid ifølge krav 5 eller et polypeptid kodet for af en nucleinsyre ifølge krav 1, (c) en blanding (eller ’’cocktail”) af hemicellulose- og cellulosehydrolyse-rende enzymer omfattende mindst en af hver af endoglucanase, en cello-biohydrolase I (CBHI), en cellobiohydrolase II (CBHII), en arabinofuranosidase, en xylanase, en oligomerase-1 (en β-glucosidase), og en oligomerase-2 eller β-xylosidase, og hvor mindst en arabinofuranosidase er et polypeptid ifølge krav 5 eller et polypeptid kodet for af en nucleinsyre ifølge krav 1, (d) et polypeptid med cellobiohydrolase l-aktivitet og et polypeptid med ara-binofuranosidaseaktivitet, hvor mindst et polypeptid med cellobiohydrolase l-aktivitet er SEQ ID NO: 34 eller SEQ ID NO: 46, og hvor mindst en arabinofuranosidase er et polypeptid ifølge krav 5 eller et polypeptid kodet for af en nucleinsyre ifølge krav 1, hvor eventuelt (i) endoglucanasen omfatter SEQ ID NO: 106, cellobiohydrolase I omfatter SEQ ID NO: 34 eller SEQ ID NO: 46, cellobiohydrolase II omfatter SEQ ID NO: 98, β-glucosidasen omfatter SEQ ID NO: 94, xylanasen omfatter SEQ ID NO: 100, SEQ ID NO: 102 eller SEQ ID NO: 524, β-xylosodasen omfatter SEQ ID NO: 96, en yderligere arabinofuranosidase, såfremt den er til stede, omfatter SEQ ID NO: 92 eller en vilkårlig kombination heraf, hvor SEQ ID NO: 106 eventuelt omfatter et yderligere carbohydratbindingsdo-mæne, (ii) blandingen omfatter en endoglucanase omfattende SEQ ID NO: 106, en oligomerase-1 (en β-glucosidase) omfattende SEQ ID NO: 522, en cellobiohydrolase I (CBHI) omfattende SEQ ID NO: 34 eller SEQ ID NO: 46, en cellobiohydrolase II (CBHII) omfattende SEQ ID NO: 98, en yderligere eventuel arabinofuranosidase, hvis til stede, omfattende SEQ ID NO: 92, en oligomerase-2 (en β-xylosidase) omfattende SEQ ID NO: 520, og en xy- lanase omfattende SEQ ID NO: 102, SEQ ID NO: 524 og/eller SEQ ID NO: 100, eller (iii) sammensætningen eller fremstillingsproduktet omfattende yderligere et biomassemateriale, hvor biomassematerialet eventuelt omfatter et lignocel-lulosemateriale afledt fra en landbrugsmæssig afgrøde, eller biomassematerialet er et biprodukt af en fødevare- eller en foderstofproduktion, eller biomassematerialet er et lignocellulosespildprodukt, eller biomassematerialet er en planteremanens eller affaldspapir eller et affaldspapirprodukt, eller biomassematerialet omfatter en planteremanens, og planteremanensen eventuelt omfatter stængler, blade, avner, majskolber, majsblade, hø, træ, træflis, træpulp og/eller savsmuld, og papiraffaldet omfatter eventuelt bortkastet og brugt fotokopieringspapir, computerprinterpapir, notesblokpapir, notesbogpapir, maskinskrivningspapir, aviser, magasiner, pap- og papirbaserede emballagematerialer.
13. Sammensætning eller fremstillingsprodukt omfattende en blanding af enzymer omfattende: (a) SEQ ID NO: 106, en cellobiohydrolase I (CBHI), en cellobiohydrolase II (CBHII) og en arabinofuranosidase i SEQ ID NO: 104, (b) blandingen fra (a), hvor CBHI er SEQ ID NO: 46 eller SEQ ID NO: 34, (c) blandingen fra (a) eller (b), hvor CBHII er SEQ ID NO: 98, (d) blandingen fra (a), (b) eller (c) omfattende en yderligere arabinofuranosidase i SEQ ID NO: 92, (e) blandingen fra (a), (b), (c) eller (d) omfattende yderligere en xylanase, (f) blandingen fra (e), hvor xylanasen er SEQ ID NO: 100, SEQ ID NO: 102 eller SEQ ID NO: 524 eller en kombination heraf, (g) blandingen fra (a), (b), (c), (d), (e) eller (f) omfattende yderligere en oligomerase, (h) blandingen fra (g), hvor oligomerasen er SEQ ID NO: 520 eller SEQ ID NO: 522 eller en kombination heraf, (i) blandingen fra (a), (b), (c), (d), (e), (f), (g) eller (h) omfattende yderligere mindst en af SEQ ID NO: 94, SEQ ID NO: 96, SEQ ID NO: 264, SEQ ID NO: 440 eller SEQ ID NO: 442 eller en kombination heraf, eller (j) blandingen fra (a), (b), (c), (d), (e), (f), (g), (h) eller (i) yderligere omfattende en endoglucanase, hvor endoglucanasen eventuelt omfatter SEQ ID NO: 108, SEQ ID NO: 112, SEQ ID NO: 114 eller SEQ ID NO: 116.
14. Enzymgruppe eller ’’cocktail” til depolymerisering af cellulose- og hæmicel-lulosepolymerer til metaboliseringsdygtige carbongrupper omfattende et po-lypeptid som anført i krav 5 eller et polypeptid kodet for af en nucleinsyre som anført i krav 1.
15. Sammensætning omfattende et polypeptid som anført i krav 5 eller et polypeptid kodet for af en nucleinsyre som anført i krav 1 eller en sammensætning eller et fremstillingsprodukt som anført i et vilkårligt af kravene 12 eller 13 eller en enzymgruppe ifølge krav 14, hvor sammensætningen eventuelt er en farmaceutisk sammensætning, en detergentsammensætning, en kontaktlinseopløsning, en spildbehandlingssammensætning, et desinficerende middel, et bioforsvarsmiddel eller et biodetyficeringsmiddel, eller hvor sammensætningen eventuelt er et brændstof, hvor sammensætningen eventuelt er en alkohol, hvor alkoholen eventuelt er ethanol, eller hvor sammensætningen eventuelt er en biomasse eller et biomassemateriale, et papir, papiraffald, genanvendt papir, papirpulp, et papirprodukt, træ, træprodukt, træpulp, tekstil, væv, garn eller fibre, eller hvor sammensætningen eventuelt er en cellulose- eller en celluloseafledt sammensætning, eller hvor eventuelt sammensætningen er en drikkevare, en fødevare, et foderstof, et mejeriprodukt eller et ernæringsmæssigt supplement, eller hvor eventuelt fødevaren er en dej, et brød eller et bagt produkt, eller hvor eventuelt drikkevaren, fødevaren, foderet eller det ernæringsmæssige supplement er til et dyr, eller hvor eventuelt biomassematerialet omfatter et lignocellu-losemateriale stammende fra en landbrugsmæssig afgrøde, eller biomassematerialet er et biprodukt af en fødevareproduktion eller en foderstofproduktion, eller biomassematerialet er et lignocelluloseaffaldsprodukt, eller biomassematerialet er en planteremanens eller et affaldspapir eller affaldspapirprodukt, eller biomassematerialet omfatter en planteremanens, og planteremanensen omfatter eventuelt stængler, blade, avner, avner, majskolber, majsblade, hø, træ, træflis, træpulp og/eller savsmuld, og affaldspapiret eventuelt omfatter bortkastet og brugt fotokopieringspapir, computerprinterpapir, notesbogpapir, notes-blokpapir, skrivemaskinepapir, aviser, magasiner, pap- og papirbaserede emballagematerialer.
16. Fremgangsmåde til at behandle eller modificere en sammensætning omfattende at bringe sammensætningen i kontakt med et polypeptid som anført i krav 5, eller et polypeptid kodet for af en nucleinsyre som anført i krav 1, eller en sammensætning eller fremstillingsprodukt som anført i et vilkårligt af kravene 12 eller 13, eller en enzymgruppering ifølge krav 14, hvor eventuelt sammensætningen er en farmaceutisk sammensætning, en detergentsammensætning, en kontaktlinseopløsning, en affaldssammensætning, et desinficerende middel, et bioforsvarsmiddel eller et biodetoxificeringsmiddel, eller hvor eventuelt sammensætningen er et brændstof, hvor eventuelt sammensætningen er en alkohol, hvor eventuelt alkoholen er ethanol, eller hvor eventuelt sammensætningen er en biomasse eller et biomassemateriale, et papir, papiraffald, genanvendt papirprodukt, papirpulp, papirprodukt, træ, træprodukt, træpulp, tekstil, væv, garn eller fibre, eller hvor eventuelt sammensætningen er en cellulose- eller cel-lulosederivatsammensætning, eller hvor eventuelt sammensætningen er en drikkevare, en fødevare, et foder, et mejeriprodukt eller et ernæringsmæssigt supplement, eller hvor eventuelt fødevaren er en dej, et brød eller et bagt produkt, eller hvor eventuelt drikkevaren, fødevaren, foderstoffet eller det ernæringsmæssige supplement er til dyr, eller hvor eventuelt biomassematerialet omfatter et lignocellulosemateriale stammende fra en landbrugsmæssig afgrøde, eller biomassematerialet er et biprodukt fra en fødevareproduktion eller en foderproduktion eller biomassematerialet er et lignocelluloseaffaldsprodukt eller biomassematerialet er en planteremanens eller et affaldspapir eller affaldspapirprodukt eller biomassematerialet omfatter en planteremanens og planteremanensen omfatter eventuelt stængler, blade, avner, avner, majskolber, majsblade, løv, træ, træflis, træpulp og/eller savsmuld og eventuelt omfatter papiraffaldet bortkastet og brugt fotokopieringspapir, computerprinterpapir, notesbog- papir, notesblokpapir, skrivemaskinepapir, aviser, magasiner, pap- og papirbaserede emballeringsmaterialer.
17. Fremgangsmåde til at hydrolysere, opbryde eller afbryde en arabinoxylan-oligomer omfattende sammensætning omfattende de følgende trin: (a) tilvejebringelse af et polypeptid med en arabinofuranosidaseaktivitet som anført i krav 5 eller et polypeptid kodet for af en nucleinsyre som anført i krav 1, eller en sammensætning eller fremstillingsprodukt som anført i et vilkårligt af kravene 12 eller 13, eller en enzymsamling ifølge krav 14, (b) tilvejebringelse af en sammensætning omfattende en arabinoxylanoli-gomer, og (c) anbringelse af polypeptidet fra trin (a) i kontakt med sammensætningen fra trin (b) ved betingelser, hvor cellulasen hydrolyserer, opbryder eller afbryder den arabinoxylanoligomeromfattende sammensætning.
18. Fremgangsmåde til at fremstille et brændstof omfattende at bringe en sammensætning i kontakt omfattende en cellulose eller en fermenteringsdygtig sukker med et polypeptid som anført i krav 5 eller et polypeptid kodet for af en nucleinsyre som anført i krav 1 eller en sammensætning eller et fremstillet produkt som anført i et vilkårligt af kravene 12 eller 13, eller en enzymgruppe ifølge krav 14, hvor eventuelt sammensætningen omfattende en cellulose eller en fermenteringsdygtig sukker omfatter en plante, planteprodukt eller plantederivat, og planten eller planteproduktet eventuelt omfatter sukkerrørsplanter eller planteprodukter, roer eller sukkerroer, hvede, majs, sojabønner, kartofler, ris eller byg, og eventuelt omfatter brændstoffet en bioethanol eller en blanding af benzin og ethanol.
19. Fremgangsmåde til forarbejdning af et biomassemateriale omfattende at bringe biomassematerialet i kontakt med et polypeptid som anført i krav 5, eller et polypeptid kodet for af en nucleinsyre som anført i krav 1, eller en sammensætning eller et fremstillet produkt som anført i et vilkårligt af kravene 12 eller 13 eller en enzymgruppering ifølge krav 14, hvor biomassematerialet eventuelt stammer fra en landbrugsmæssig afgrøde, er et biprodukt af en fødevare- eller foderproduktion, er et lignocelluloseaffalds-produkt eller er en planteremanens eller et affaldspapir eller et affaldspapirprodukt, og planteremanensen eventuelt omfatter stængler, blade, avner, avner, majskolber, majsblade, hø, træ, træflis, træpulp og savsmuld, og papiraffaldet omfatter bortkastet eller brugt fotokopieringspapir, computerprinterpapir, notes-bogpapir, notesblokpapir, skrivemaskinepapir, aviser, magasiner, pap- og papirbaserede emballeringsmaterialer og eventuelt genererer forarbejdningen af biomassematerialet en bioethanol.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77278606P | 2006-02-10 | 2006-02-10 | |
| EP20060845040 EP1989301B1 (en) | 2006-02-10 | 2006-12-08 | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2420570T3 true DK2420570T3 (da) | 2014-03-10 |
Family
ID=38371947
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11007476T DK2450439T3 (da) | 2006-02-10 | 2006-12-08 | Cellulosenedbrydende enzymer, nucleinsyrer, der koder for dem, og fremgangsmåder til at fremstille og benytte dem |
| DK06845040T DK1989301T3 (da) | 2006-02-10 | 2006-12-08 | Cellulolytiske enzymer, nucleinsyrer, som koder for dem, og fremgangsmåder til at fremstille og anvende dem |
| DK11007471.3T DK2444487T3 (da) | 2006-02-10 | 2006-12-08 | Cellulolytiske enzymer, nukleinsyrer, der koder for dem, samt fremgangsmåder til deres fremstilling og anvendelse |
| DK11007477T DK2420570T3 (da) | 2006-02-10 | 2006-12-08 | Arabinofuranosidaseenzymer, nucleinsyrer, som koder for dem, og fremgangsmåder til at fremstille og anvende dem |
| DK11007472T DK2415864T3 (da) | 2006-02-10 | 2006-12-08 | Oligomerase-2-enzymer (eller beta-xylosidaseenzymer), nucleinsyrer, som koder for dem, og fremgangsmåder til at fremstille og anvende dem |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11007476T DK2450439T3 (da) | 2006-02-10 | 2006-12-08 | Cellulosenedbrydende enzymer, nucleinsyrer, der koder for dem, og fremgangsmåder til at fremstille og benytte dem |
| DK06845040T DK1989301T3 (da) | 2006-02-10 | 2006-12-08 | Cellulolytiske enzymer, nucleinsyrer, som koder for dem, og fremgangsmåder til at fremstille og anvende dem |
| DK11007471.3T DK2444487T3 (da) | 2006-02-10 | 2006-12-08 | Cellulolytiske enzymer, nukleinsyrer, der koder for dem, samt fremgangsmåder til deres fremstilling og anvendelse |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11007472T DK2415864T3 (da) | 2006-02-10 | 2006-12-08 | Oligomerase-2-enzymer (eller beta-xylosidaseenzymer), nucleinsyrer, som koder for dem, og fremgangsmåder til at fremstille og anvende dem |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US8101393B2 (da) |
| EP (9) | EP2420570B1 (da) |
| CN (3) | CN103555741A (da) |
| AU (1) | AU2006338208B2 (da) |
| BR (1) | BRPI0621331A2 (da) |
| CA (1) | CA2637013A1 (da) |
| DK (5) | DK2450439T3 (da) |
| MY (8) | MY161027A (da) |
| NZ (9) | NZ595497A (da) |
| WO (1) | WO2007094852A2 (da) |
Families Citing this family (89)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030051836A1 (en) * | 2001-05-21 | 2003-03-20 | Novozymes A/S | Enzymatic hydrolysis of a polymer comprising vinyl acetate monomer |
| US7024800B2 (en) | 2004-07-19 | 2006-04-11 | Earthrenew, Inc. | Process and system for drying and heat treating materials |
| US7685737B2 (en) | 2004-07-19 | 2010-03-30 | Earthrenew, Inc. | Process and system for drying and heat treating materials |
| US7610692B2 (en) | 2006-01-18 | 2009-11-03 | Earthrenew, Inc. | Systems for prevention of HAP emissions and for efficient drying/dehydration processes |
| NZ598285A (en) * | 2007-01-30 | 2013-10-25 | Syngenta Participations Ag | Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| US7923236B2 (en) * | 2007-08-02 | 2011-04-12 | Dyadic International (Usa), Inc. | Fungal enzymes |
| BRPI0817811A2 (pt) * | 2007-10-03 | 2014-10-14 | Verenium Corp | Xilanases, ácidos nucleicos que codificam as mesmas e métodos para fabricação e uso das mesmas. |
| CA2707017A1 (en) * | 2007-11-30 | 2009-06-11 | Novozymes A/S | Polypeptides having arabinofuranosidase activity and polynucleotides encoding same |
| FR2926824A1 (fr) * | 2008-01-25 | 2009-07-31 | Cie Ind De La Matiere Vegetale | Procede de pretraitement d'une matiere vegetale lignocellulosique en vue de la production de bioethanol. |
| CA2724076C (en) | 2008-05-11 | 2018-11-27 | Universiteit Stellenbosch | Heterologous expression of fungal cellobiohydrolases in yeast |
| CN101348776B (zh) * | 2008-07-31 | 2011-08-17 | 中国农业科学院北京畜牧兽医研究所 | 分泌酸性纤维素酶的转基因乳酸菌及其制备方法和应用 |
| WO2010048522A1 (en) | 2008-10-24 | 2010-04-29 | C5-6 Technologies, Inc. | Thermostable cellulase and methods of use |
| WO2010059424A2 (en) | 2008-11-18 | 2010-05-27 | Novozymes, Inc. | Methods and compositions for degrading cellulosic material |
| WO2010124266A2 (en) * | 2009-04-24 | 2010-10-28 | The Regents Of The University Of California | Thermostable cellulases, and mutants thereof, capable of hydrolyzing cellulose in ionic liquid |
| WO2010129287A2 (en) | 2009-04-27 | 2010-11-11 | The Board Of Trustees Of The University Of Illinois | Hemicellulose-degrading enzymes |
| CN101870966B (zh) * | 2009-04-27 | 2012-08-01 | 复旦大学 | 葡萄糖苷酶/木糖苷酶双功能纤维素降解酶及其制备方法和应用 |
| MX353237B (es) | 2009-09-23 | 2018-01-08 | Danisco Us Inc | Enzimas de glicosil hidrolasa novedosas y usos de las mismas. |
| US9267125B2 (en) * | 2009-11-06 | 2016-02-23 | Novozymes, Inc. | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| US20130071884A1 (en) | 2009-11-06 | 2013-03-21 | Agrivida, Inc. | Plants expressing cell wall degrading enzymes and expression vectors |
| RU2012131405A (ru) | 2009-12-23 | 2014-01-27 | ДАНИСКО ЮЭс ИНК. | Способы улучшения эффективности одновременно протекающих реакций осахаривания и ферментации |
| FI122937B (fi) | 2009-12-30 | 2012-09-14 | Roal Oy | Menetelmä selluloosamateriaalin käsittelemiseksi sekä tässä käyttökelpoiset CBH II/Cel6A entsyymit |
| US9133448B2 (en) * | 2010-02-11 | 2015-09-15 | Dsm Ip Assets B.V. | Polypeptide having cellobiohydrolase activity and uses thereof |
| EP2536842A1 (en) | 2010-02-15 | 2012-12-26 | Yeda Research and Development Co. Ltd. | Bio-engineered multi-enzyme complexes comprising xylanases and uses thereof |
| CN102918151B (zh) * | 2010-03-31 | 2015-09-09 | 诺维信股份有限公司 | 纤维二糖水解酶变体及编码其的多核苷酸 |
| JP5628544B2 (ja) * | 2010-04-07 | 2014-11-19 | 株式会社豊田中央研究所 | クロストリジウム・サーモセラム由来のタンパク質複合体を構築するためのタンパク質及びその利用 |
| ES2371317B1 (es) * | 2010-06-14 | 2012-11-07 | Consejo Superior De Investigaciones Científicas (Csic) | Endoxilanasa termorresistente obtenida por mutagénesis y su aplicación al proceso de obtención de bioetanol. |
| CN101906406B (zh) * | 2010-06-24 | 2012-10-17 | 复旦大学 | 具有内切葡聚糖酶/木聚糖酶活性的双功能酶及其制备方法与应用 |
| US10443068B2 (en) | 2010-06-25 | 2019-10-15 | Agrivida, Inc. | Plants with engineered endogenous genes |
| US9598700B2 (en) | 2010-06-25 | 2017-03-21 | Agrivida, Inc. | Methods and compositions for processing biomass with elevated levels of starch |
| DK2735611T3 (da) | 2010-08-30 | 2019-01-28 | Novozymes As | Polypeptider med cellulolyseforøgende aktivitet og polynukleotider, som koder for dem |
| US9267126B2 (en) | 2010-08-30 | 2016-02-23 | Novozymes, Inc. | Polypeptides having endoglucanase activity and polynucleotides encoding same |
| US9187742B2 (en) * | 2010-08-30 | 2015-11-17 | Novozymes, Inc. | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same |
| CA2811206A1 (en) * | 2010-09-15 | 2012-03-22 | The Regents Of The University Of California | Thermophilic mutants of trichoderma reesei endoglucanase i |
| US9096871B2 (en) * | 2010-10-06 | 2015-08-04 | Bp Corporation North America Inc. | Variant CBH I polypeptides with reduced product inhibition |
| KR20130132789A (ko) * | 2010-11-05 | 2013-12-05 | 아사히 가라스 가부시키가이샤 | 스키조사카로미세스속 효모의 형질 전환체 및 그 제조 방법 |
| US20140147873A1 (en) * | 2011-03-03 | 2014-05-29 | The Regents Of The University Of California | Surface display of cellulolytic enzymes and enzyme complexes on gram-positive microorganisms |
| CA2829207C (en) * | 2011-03-07 | 2022-10-11 | Agrivida, Inc. | Consolidated pretreatment and hydrolysis of plant biomass expressing cell wall degrading enzymes |
| CN103492561A (zh) * | 2011-03-17 | 2014-01-01 | 丹尼斯科美国公司 | 纤维素酶组合物和使用相同组合物用于改善木质纤维素生物质转化成可发酵糖的方法 |
| SG192025A1 (en) * | 2011-03-17 | 2013-08-30 | Danisco Us Inc | Glycosyl hydrolase enzymes and uses thereof for biomass hydrolysis |
| US20140134677A1 (en) * | 2011-03-17 | 2014-05-15 | Danisco Us Inc. | Method for reducing viscosity in saccharification process |
| CN103562382A (zh) * | 2011-03-25 | 2014-02-05 | 诺维信公司 | 用于降解或转化纤维素材料的方法 |
| CN103608356A (zh) * | 2011-04-29 | 2014-02-26 | 丹尼斯科美国公司 | 包含黏琼脂芽孢杆菌(Bacillus agaradhaerens)甘露聚糖酶的洗涤剂组合物及其使用方法 |
| US8835141B2 (en) * | 2011-06-09 | 2014-09-16 | The United States Of America As Represented By The Secretary Of Agriculture | Methods for integrated conversion of lignocellulosic material to sugars or biofuels and nano-cellulose |
| WO2013103127A1 (ja) * | 2012-01-06 | 2013-07-11 | 本田技研工業株式会社 | 糖化酵素組成物及びそれを用いる糖化溶液の製造方法 |
| EA028648B1 (ru) * | 2012-03-30 | 2017-12-29 | Басф Энзаймс Ллк | Ген, кодирующий целлюлазу (варианты) |
| US8980578B2 (en) | 2012-06-11 | 2015-03-17 | Codexis, Inc. | Fungal beta-xylosidase variants |
| CN102827819B (zh) * | 2012-08-08 | 2014-03-12 | 天津工业生物技术研究所 | 一种β-木糖苷酶及其应用 |
| WO2014070856A2 (en) | 2012-11-02 | 2014-05-08 | Bp Corporation North America Inc. | Thermotolerant beta-glucosidase variants |
| CN104870636A (zh) * | 2012-12-07 | 2015-08-26 | 丹尼斯科美国公司 | 组合物及使用方法 |
| BR112015012968A2 (pt) * | 2012-12-07 | 2017-09-12 | Danisco Us Inc | composições e métodos de uso |
| EP2929023B1 (en) * | 2012-12-07 | 2017-08-16 | Danisco US Inc. | Compositions and methods of use |
| BR112015012986A2 (pt) * | 2012-12-07 | 2017-09-12 | Danisco Us Inc | composições e métodos de uso |
| US9850512B2 (en) | 2013-03-15 | 2017-12-26 | The Research Foundation For The State University Of New York | Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield |
| US9493751B2 (en) * | 2013-03-15 | 2016-11-15 | Academia Sinica | Dual-functional hybrid glucanases |
| US20140356913A1 (en) * | 2013-03-29 | 2014-12-04 | Matthew Wayne Parrow | Enzymes Manufactured in Transgenic Soybean for Plant Biomass Engineering and Organopollutant Bioremediation |
| HUE047670T2 (hu) * | 2013-05-18 | 2020-05-28 | Direvo Ind Biotechnology Gmbh | Enzimkészítmények a fermentációs folyamatok és melléktermékek javítására |
| JP6449272B2 (ja) * | 2013-07-08 | 2019-01-09 | ナンジン レジェンド バイオテック カンパニー,リミテッドNanjing Legend Biotech Co.,Ltd. | タンパク質の血清半減期を増加する組成物及び方法 |
| US9951363B2 (en) | 2014-03-14 | 2018-04-24 | The Research Foundation for the State University of New York College of Environmental Science and Forestry | Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects |
| US10494655B2 (en) | 2014-04-03 | 2019-12-03 | Universiti Brunei Darussalam | Synthetic fusion gene and its use thereof |
| GB201409047D0 (en) * | 2014-05-21 | 2014-07-02 | Cellucomp Ltd | Cellulose microfibrils |
| US10047351B2 (en) * | 2014-05-27 | 2018-08-14 | National Institute Of Advanced Industrial Science And Technology | Cellobiohydrolase having improved thermal stability |
| JP2016029908A (ja) * | 2014-07-28 | 2016-03-07 | 本田技研工業株式会社 | Ghファミリー10に属する耐熱性キシラナーゼ |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| AR102445A1 (es) * | 2014-10-27 | 2017-03-01 | Danisco Us Inc | COMPOSICIONES Y MÉTODOS RELACIONADOS CON b-GLUCOSIDASA |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| GB201509149D0 (en) | 2015-05-28 | 2015-07-15 | Sintef | Thermostatable Cellulases |
| US20180216089A1 (en) * | 2015-07-24 | 2018-08-02 | Novozymes, Inc. | Polypeptides Having Beta-Xylosidase Activity And Polynucleotides Encoding Same |
| WO2017063787A1 (en) * | 2015-10-15 | 2017-04-20 | Technische Universitaet Muenchen | Mutant beta-glucosidase variants with increased thermostability |
| CN108603184B (zh) * | 2016-02-18 | 2022-09-16 | 百奥普拉特公司 | 阿拉伯聚糖酶及其用途 |
| CN106338453A (zh) * | 2016-08-26 | 2017-01-18 | 浙江海申新材料有限公司 | 一种快速检测纤维素醚防霉性能的方法 |
| IL247569A0 (en) | 2016-08-30 | 2016-11-30 | Yeda Res & Dev | An enzymatic complex for the breakdown of lignocellulosic material |
| EP3545003A4 (en) * | 2016-11-25 | 2020-12-09 | Novozymes A/S | GH10 XYLANASE, GH62 ARABINOFURANOSIDASE, CRUSHING PROCESS AND OTHER APPLICATION |
| WO2018106656A1 (en) | 2016-12-06 | 2018-06-14 | Danisco Us Inc | Truncated lpmo enzymes and use thereof |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CA3070606A1 (en) * | 2017-07-24 | 2019-01-31 | North Carolina State University | Compositions and methods for increasing phytochemical bioavailablity and bioactivity |
| CN119264211A (zh) | 2018-08-27 | 2025-01-07 | 瑞泽恩制药公司 | 拉曼光谱在下游纯化中的应用 |
| CN109182358B (zh) * | 2018-09-17 | 2022-02-08 | 黑龙江省农业科学院耕作栽培研究所 | 适用于水稻秸秆还田的芽孢杆菌纤维素酶基因fib1x |
| CN109504632B (zh) * | 2018-12-18 | 2022-02-25 | 河北农业大学 | 一株枯草芽孢杆菌及其应用 |
| CN113496760B (zh) * | 2020-04-01 | 2024-01-12 | 深圳华大基因科技服务有限公司 | 基于第三代测序的多倍体基因组组装方法和装置 |
| WO2021248045A2 (en) * | 2020-06-04 | 2021-12-09 | California Institute Of Technology | Novel signal peptides generated by attention-based neural networks |
| JP7634960B2 (ja) * | 2020-10-28 | 2025-02-25 | 花王株式会社 | 改変シグナルペプチド |
| EP4052581A1 (en) * | 2021-03-03 | 2022-09-07 | AB Enzymes GmbH | Use of gh12 cellulases in spelt, oat, barley, and / or millet baking |
| WO2023114930A1 (en) * | 2021-12-15 | 2023-06-22 | The George Washington University | Compositions for and methods of improving directed evolution of biomolecules |
| CN115500382B (zh) * | 2021-12-27 | 2024-07-30 | 君乐宝乳业集团股份有限公司 | 一种脱冷控制后酸的乳酸菌饮料及其制备方法 |
| CN114628036B (zh) * | 2022-05-17 | 2022-08-02 | 中南大学湘雅医院 | 基于神经网络的脑缺血风险预估平台 |
| DE102023001827A1 (de) | 2023-04-19 | 2024-10-24 | Horst Wochnowski | Verfahren und dazugehörige Vorrichtung zum Züchten von in Gewässern Mikroplastik zersetzenden und abbauenden Mikroorganismenstämme durch einen künstlich herbeigeführten und beschleunigten Evolutions- und Selektionsprozess |
| CN117143848B (zh) * | 2023-07-17 | 2025-01-21 | 大理大学 | 一种耐盐β-葡萄糖苷酶及应用 |
| CN118308396A (zh) * | 2024-05-16 | 2024-07-09 | 浙江工业大学 | 用于遗传转化的重组多粘类芽孢杆菌及其构建方法 |
Family Cites Families (195)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1138583A (en) | 1914-11-09 | 1915-05-04 | Thomas H Tasker | Ladder-support. |
| US5366558A (en) | 1979-03-23 | 1994-11-22 | Brink David L | Method of treating biomass material |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US5021246A (en) | 1984-03-30 | 1991-06-04 | Anheuser-Busch, Incorporated | Step mashing process for producing low alcohol beer |
| US5087571A (en) | 1984-06-22 | 1992-02-11 | President And Fellows Of Harvard College | Method for providing a cell culture from a transgenic non-human mammal |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| DE229046T1 (de) | 1985-03-30 | 1987-12-17 | Marc Genf/Geneve Ballivet | Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren. |
| US4962028A (en) | 1986-07-09 | 1990-10-09 | Dna Plant Technology Corporation | Plant promotors |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US5015580A (en) | 1987-07-29 | 1991-05-14 | Agracetus | Particle-mediated transformation of soybean plants and lines |
| US5573933A (en) | 1987-04-14 | 1996-11-12 | Luminis Pty, Ltd. | Transgenic pigs |
| US4788066A (en) | 1987-12-14 | 1988-11-29 | Grain Processing Corporation | Preparation of low alcohol beer |
| US6054270A (en) | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
| US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
| US5217879A (en) | 1989-01-12 | 1993-06-08 | Washington University | Infectious Sindbis virus vectors |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5589583A (en) | 1990-01-11 | 1996-12-31 | Monsanto Company | Plant promoter |
| WO1991016427A1 (en) | 1990-04-24 | 1991-10-31 | Stratagene | Methods for phenotype creation from multiple gene populations |
| US5326477A (en) | 1990-05-07 | 1994-07-05 | Bio-Sep, Inc. | Process for digesting solid waste |
| DK0531372T4 (da) | 1990-05-09 | 2004-08-09 | Novozymes As | Cellulasepræparat omfattende et endoglucanaseenzym |
| ES2217250T3 (es) | 1990-06-15 | 2004-11-01 | Scios Inc. | Mamifero transgenico, no humano que muestra la patologia de formacion amiloides de la enfermedad de alzheimer. |
| ES2260886T3 (es) | 1990-11-23 | 2006-11-01 | Bayer Bioscience N.V. | Procedimiento para transformar plantas monocotiledoneas. |
| ES2322032T3 (es) | 1990-12-10 | 2009-06-16 | Genencor Int | Sacrificacion mejorada de celulosa por clonacion y amplificacion del gen de beta-glucosidasa de trichoderma reesei. |
| JP3298879B2 (ja) | 1990-12-20 | 2002-07-08 | イグジス,インコーポレイテッド | 結合タンパク質の最適化 |
| NL9100050A (nl) | 1991-01-11 | 1992-08-03 | Heineken Technische Beheer Bv | Werkwijze voor het continu bereiden van wort. |
| US5405624A (en) | 1991-02-14 | 1995-04-11 | Bio-Technical Resources | Process for producing a product with an intensified beer flavor |
| US6110700A (en) | 1991-03-11 | 2000-08-29 | The General Hospital Corporation | PRAD1 cyclin and its cDNA |
| US5922854A (en) | 1991-06-14 | 1999-07-13 | Kumar; Ramesh | Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids |
| CA2075135A1 (en) | 1991-08-02 | 1993-02-03 | David E. Ellis | Particle-mediated transformation of gymnosperms |
| US5632957A (en) | 1993-11-01 | 1997-05-27 | Nanogen | Molecular biological diagnostic systems including electrodes |
| JPH05236997A (ja) | 1992-02-28 | 1993-09-17 | Hitachi Ltd | ポリヌクレオチド捕捉用チップ |
| US5550046A (en) | 1992-03-27 | 1996-08-27 | Toyo Boseki Kabushiki Kaisha | DNA encoding α-glucosidase and method of producing same by genetic engineering |
| AU5676394A (en) | 1992-11-20 | 1994-06-22 | Agracetus, Inc. | Transgenic cotton plants producing heterologous bioplastic |
| BR9307805A (pt) | 1992-12-31 | 1996-07-30 | Metallgesellschaft Ag | Processo para a preparaçao de cerveja |
| AU7925094A (en) | 1993-09-30 | 1995-04-18 | Agracetus, Inc. | Transgenic cotton plants producing heterologous peroxidase |
| US6045996A (en) | 1993-10-26 | 2000-04-04 | Affymetrix, Inc. | Hybridization assays on oligonucleotide arrays |
| US5965452A (en) | 1996-07-09 | 1999-10-12 | Nanogen, Inc. | Multiplexed active biologic array |
| US6468742B2 (en) | 1993-11-01 | 2002-10-22 | Nanogen, Inc. | Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip |
| DK131193D0 (da) | 1993-11-23 | 1993-11-23 | Novo Nordisk As | |
| US5571703A (en) | 1993-12-23 | 1996-11-05 | Controlled Environmental Systems Corporation | Municipal solid waste processing facility and commercial ethanol production process |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5639940A (en) | 1994-03-03 | 1997-06-17 | Pharmaceutical Proteins Ltd. | Production of fibrinogen in transgenic animals |
| WO1995024494A1 (en) | 1994-03-09 | 1995-09-14 | Abbott Laboratories | Humanized milk |
| AU692841B2 (en) | 1994-03-09 | 1998-06-18 | Abbott Laboratories | Transgenic animals producing oligosaccharides and glycoconjugates |
| US5824531A (en) | 1994-03-29 | 1998-10-20 | Novid Nordisk | Alkaline bacilus amylase |
| US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
| US5750870A (en) | 1994-06-17 | 1998-05-12 | Agritope, Inc. | Plant genetic transformation methods and transgenic plants |
| US5582681A (en) | 1994-06-29 | 1996-12-10 | Kimberly-Clark Corporation | Production of soft paper products from old newspaper |
| US5959171A (en) | 1994-08-17 | 1999-09-28 | Pharming B.V. | Method for the production of biologically active polypeptides in a mammal's |
| WO1996006927A1 (en) | 1994-09-01 | 1996-03-07 | Merck & Co., Inc. | Transgenic animal expressing a familial form of human amyloid precursor protein |
| US5423145A (en) * | 1994-09-16 | 1995-06-13 | Nasset; James L. | Rifle-barrel harmonic vibration tuning device |
| US6111166A (en) | 1994-09-19 | 2000-08-29 | Medarex, Incorporated | Transgenic mice expressing human Fcα and β receptors |
| US5795737A (en) | 1994-09-19 | 1998-08-18 | The General Hospital Corporation | High level expression of proteins |
| US5880327A (en) | 1994-09-21 | 1999-03-09 | American National Red Cross | Transgenic mammals expressing human coagulation factor VIII |
| US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
| US6187992B1 (en) | 1994-12-05 | 2001-02-13 | Merck & Co., Inc. | Transgenic mouse having a disrupted amyloid precursor protein gene |
| US5830645A (en) | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
| US5633440A (en) | 1994-12-20 | 1997-05-27 | Dna Plant Technology Corporation | P119 promoters and their uses |
| US5705369A (en) | 1994-12-27 | 1998-01-06 | Midwest Research Institute | Prehydrolysis of lignocellulose |
| CN1165614C (zh) | 1995-01-26 | 2004-09-08 | 诺沃奇梅兹有限公司 | 含有木聚糖酶的动物饲料添加剂 |
| US6093562A (en) | 1996-02-05 | 2000-07-25 | Novo Nordisk A/S | Amylase variants |
| US5959098A (en) | 1996-04-17 | 1999-09-28 | Affymetrix, Inc. | Substrate preparation process |
| AU698739B2 (en) | 1995-06-06 | 1998-11-05 | Isis Pharmaceuticals, Inc. | Oligonucleotides having phosphorothioate linkages of high chiral purity |
| CN1188510A (zh) * | 1995-06-23 | 1998-07-22 | 丹尼斯科成分公司(丹尼斯科公司) | 新的β-木糖苷酶和编码该酶的核苷酸序列以及该酶的用途 |
| US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
| FR2736359B1 (fr) | 1995-07-06 | 1997-10-03 | Agronomique Inst Nat Rech | Beta-glucosidase de champignons filamenteaux, et ses utilisations |
| US5985662A (en) | 1995-07-13 | 1999-11-16 | Isis Pharmaceuticals Inc. | Antisense inhibition of hepatitis B virus replication |
| US5958672A (en) | 1995-07-18 | 1999-09-28 | Diversa Corporation | Protein activity screening of clones having DNA from uncultivated microorganisms |
| US6057103A (en) | 1995-07-18 | 2000-05-02 | Diversa Corporation | Screening for novel bioactivities |
| EP0839224A1 (en) | 1995-07-19 | 1998-05-06 | Novo Nordisk A/S | Treatment of fabrics |
| US5962258A (en) | 1995-08-23 | 1999-10-05 | Diversa Corporation | Carboxymethyl cellulase fromthermotoga maritima |
| WO1997016533A1 (en) | 1995-10-31 | 1997-05-09 | The Regents Of The University Of California | Mammalian artificial chromosomes and methods of using same |
| US6171820B1 (en) | 1995-12-07 | 2001-01-09 | Diversa Corporation | Saturation mutagenesis in directed evolution |
| US5965408A (en) | 1996-07-09 | 1999-10-12 | Diversa Corporation | Method of DNA reassembly by interrupting synthesis |
| US6358709B1 (en) | 1995-12-07 | 2002-03-19 | Diversa Corporation | End selection in directed evolution |
| US6740506B2 (en) | 1995-12-07 | 2004-05-25 | Diversa Corporation | End selection in directed evolution |
| US20030215798A1 (en) | 1997-06-16 | 2003-11-20 | Diversa Corporation | High throughput fluorescence-based screening for novel enzymes |
| US5939250A (en) | 1995-12-07 | 1999-08-17 | Diversa Corporation | Production of enzymes having desired activities by mutagenesis |
| US6361974B1 (en) | 1995-12-07 | 2002-03-26 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
| US6537776B1 (en) | 1999-06-14 | 2003-03-25 | Diversa Corporation | Synthetic ligation reassembly in directed evolution |
| US5830696A (en) | 1996-12-05 | 1998-11-03 | Diversa Corporation | Directed evolution of thermophilic enzymes |
| US6939689B2 (en) | 1995-12-07 | 2005-09-06 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
| US6022963A (en) | 1995-12-15 | 2000-02-08 | Affymetrix, Inc. | Synthesis of oligonucleotide arrays using photocleavable protecting groups |
| US6013440A (en) | 1996-03-11 | 2000-01-11 | Affymetrix, Inc. | Nucleic acid affinity columns |
| US6127160A (en) | 1996-03-14 | 2000-10-03 | Japan As Represented By Director General Of Agency Of Industrial Science And Technology | Protein having cellulase activities and process for producing the same |
| US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
| US6025155A (en) | 1996-04-10 | 2000-02-15 | Chromos Molecular Systems, Inc. | Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |
| US5697987A (en) | 1996-05-10 | 1997-12-16 | The Trustees Of Princeton University | Alternative fuel |
| US6197070B1 (en) | 1996-05-15 | 2001-03-06 | The Procter & Gamble Company | Detergent compositions comprising alpha combination of α-amylases for malodor stripping |
| US6057100A (en) | 1996-06-07 | 2000-05-02 | Eos Biotechnology, Inc. | Oligonucleotide arrays |
| US5833857A (en) | 1996-06-07 | 1998-11-10 | Lytal Family Trust | Mobile Bioreactor and Biogenerator |
| US5747320A (en) | 1996-08-02 | 1998-05-05 | The United States Of America, As Represented By The Secretary Of Agriculture | Glucose and cellobiose tolerant β-glucosidase from Candida peltata |
| AU4067297A (en) | 1996-08-16 | 1998-03-06 | International Paper Company | Enzymatic freeness enhancement |
| US6326341B1 (en) | 1996-09-11 | 2001-12-04 | The Procter & Gamble Company | Low foaming automatic dishwashing compositions |
| US6069122A (en) | 1997-06-16 | 2000-05-30 | The Procter & Gamble Company | Dishwashing detergent compositions containing organic diamines for improved grease cleaning, sudsing, low temperature stability and dissolution |
| US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| KR100570935B1 (ko) | 1997-01-17 | 2006-04-13 | 맥시겐, 인크. | 반복적 서열 재조합에 의한 전세포 및 유기체의 개량 방법 |
| DE19703364A1 (de) | 1997-01-30 | 1998-08-06 | Henkel Ecolab Gmbh & Co Ohg | Pastenförmiges Wasch- und Reinigungsmittel |
| ATE418608T1 (de) | 1997-03-18 | 2009-01-15 | Novozymes As | Methode zur herstellung einer bibliothek mittels dna-shuffling |
| BR9808404A (pt) | 1997-03-18 | 2000-05-16 | 2B Ag | Processo para aproveitamento de biomassa vegetal e prensa helicoidal para realização desse processo |
| WO1998041653A1 (en) | 1997-03-18 | 1998-09-24 | Novo Nordisk A/S | An in vitro method for construction of a dna library |
| US5948653A (en) | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
| US6153410A (en) | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
| US6333181B1 (en) | 1997-04-07 | 2001-12-25 | University Of Florida Research Foundation, Inc. | Ethanol production from lignocellulose |
| RU2127760C1 (ru) | 1997-04-22 | 1999-03-20 | Акционерное общество открытого типа "Туласпирт" спиртоводочный завод "Лужковский" | Способ производства этилового спирта из зернового сырья |
| US5916780A (en) | 1997-06-09 | 1999-06-29 | Iogen Corporation | Pretreatment process for conversion of cellulose to fuel ethanol |
| US7019827B2 (en) | 1997-06-16 | 2006-03-28 | Diversa Corporation | GigaMatrix holding tray having through-hole wells |
| AUPO758297A0 (en) | 1997-06-27 | 1997-07-24 | Rowe, James Baber | Control of acidic gut syndrome |
| NZ328434A (en) | 1997-07-24 | 1998-05-27 | Univ British Columbia Substitu | Coniferin beta-glucosidase cdna for modifying lignin content in plants |
| US6826296B2 (en) | 1997-07-25 | 2004-11-30 | Affymetrix, Inc. | Method and system for providing a probe array chip design database |
| US5958758A (en) | 1997-08-04 | 1999-09-28 | Biosun Systems Corporation | Treatment of animal waste |
| EP1012335A4 (en) | 1997-08-15 | 2004-06-09 | Hyseq Inc | EXPERIENCE AND COMPOSITIONS FOR DETECTING OR QUANTIFYING NUCLEIC ACID SPECIES |
| IL134702A (en) | 1997-09-11 | 2004-03-28 | Bioventures Inc | High density arrays and methods of making the same |
| US6465178B2 (en) | 1997-09-30 | 2002-10-15 | Surmodics, Inc. | Target molecule attachment to surfaces |
| US6399383B1 (en) | 1997-10-28 | 2002-06-04 | Maxygen, Inc. | Human papilloma virus vectors |
| US6204232B1 (en) | 1997-10-30 | 2001-03-20 | Novo Nordisk A/S | α-amlase mutants |
| EP1030861A4 (en) | 1997-10-31 | 2001-09-05 | Maxygen Inc | MODIFICATION OF VIRUSTROPISMIUS AND THE ECONOMIC SPECTRUM BY VIRAL GENOM MIXING |
| EP1032644B1 (en) | 1997-11-10 | 2003-03-19 | The Procter & Gamble Company | Process for preparing a detergent tablet |
| DE69828574T2 (de) | 1997-11-14 | 2005-10-06 | Sankyo Co., Ltd. | Transgenes Tier als Modell für Allergie und seine Verwendung |
| US6537746B2 (en) | 1997-12-08 | 2003-03-25 | Maxygen, Inc. | Method for creating polynucleotide and polypeptide sequences |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| EP1054973A1 (en) | 1998-02-11 | 2000-11-29 | Maxygen, Inc. | Antigen library immunization |
| AU3291099A (en) | 1998-02-11 | 1999-08-30 | Maxygen, Inc. | Genetic vaccine vector engineering |
| CA2323638A1 (en) | 1998-04-03 | 1999-10-14 | Phylos, Inc. | Addressable protein arrays |
| US6156952A (en) | 1998-04-09 | 2000-12-05 | Constituent Institution Of The University Of Maryland System | HIV transgenic animals and uses therefor |
| JP2003527450A (ja) | 1998-05-01 | 2003-09-16 | ノボ ノルディスク アクティーゼルスカブ | N−ヒドロキシアセトアニリドの様な増強剤 |
| US6048695A (en) | 1998-05-04 | 2000-04-11 | Baylor College Of Medicine | Chemically modified nucleic acids and methods for coupling nucleic acids to solid support |
| EP0976838A1 (en) | 1998-05-06 | 2000-02-02 | Rhone-Poulenc Nutrition Animale | Enzymes mixture |
| WO1999057287A2 (en) | 1998-05-06 | 1999-11-11 | University Of Georgia Research Foundation, Inc. | Beta-glucosidase coding sequences and protein from orpinomyces pc-2 |
| DE19824705A1 (de) | 1998-06-03 | 1999-12-09 | Henkel Kgaa | Amylase und Protease enthaltende Wasch- und Reinigungsmittel |
| IL140100A0 (en) | 1998-06-29 | 2002-02-10 | Phylos Inc | Methods of generating highly diverse libraries |
| JP4335995B2 (ja) | 1998-07-22 | 2009-09-30 | 昭 神谷 | 環境保全型粒状洗浄用組成物 |
| FR2782323B1 (fr) | 1998-08-12 | 2002-01-11 | Proteus | Procede de production in vitro de sequences polynucleotidiques recombinees, banques de sequences et sequences ainsi obtenues |
| GB2340755B (en) | 1998-08-24 | 2002-09-25 | Cannon Rubber Ltd | Breast pump insert |
| US6602700B1 (en) | 1998-09-04 | 2003-08-05 | University Of Georgia Research Foundation, Inc. | Phenolic acid esterases, coding sequences and methods |
| AU6046199A (en) | 1998-09-17 | 2000-04-03 | Novozymes North America, Inc. | Methods for deinking and decolorizing printed paper |
| US6277628B1 (en) | 1998-10-02 | 2001-08-21 | Incyte Genomics, Inc. | Linear microarrays |
| EP1123974B1 (en) | 1998-10-23 | 2010-05-05 | Meiji Seika Kaisha Ltd. | Endoglucanases and cellulase preparations containing the same |
| US6277489B1 (en) | 1998-12-04 | 2001-08-21 | The Regents Of The University Of California | Support for high performance affinity chromatography and other uses |
| US7220542B2 (en) | 2000-07-17 | 2007-05-22 | Van Den Brink Johannes Maarten | Expression cloning in filamentous fungi |
| AU1685600A (en) | 1998-12-24 | 2000-07-31 | Takara Shuzo Co., Ltd. | Polypeptides |
| US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
| US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US6368861B1 (en) | 1999-01-19 | 2002-04-09 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US6511824B1 (en) | 1999-03-17 | 2003-01-28 | Exelixis, Inc. | Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use |
| US6309871B1 (en) | 1999-03-31 | 2001-10-30 | Novozymes A/S | Polypeptides having alkaline α-amylase activity |
| US6221653B1 (en) | 1999-04-27 | 2001-04-24 | Agilent Technologies, Inc. | Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids |
| US6653151B2 (en) | 1999-07-30 | 2003-11-25 | Large Scale Proteomics Corporation | Dry deposition of materials for microarrays using matrix displacement |
| US6409841B1 (en) | 1999-11-02 | 2002-06-25 | Waste Energy Integrated Systems, Llc. | Process for the production of organic products from diverse biomass sources |
| CA2360750A1 (en) | 1999-11-22 | 2001-05-31 | Diversa Corporation | Capillary array-based sample screening |
| US20010008765A1 (en) | 1999-12-06 | 2001-07-19 | Fuji Photo Film Co., Ltd. | DNA chip and reactive solid carrier |
| US6531644B1 (en) | 2000-01-14 | 2003-03-11 | Exelixis, Inc. | Methods for identifying anti-cancer drug targets |
| WO2001070998A1 (en) | 2000-03-20 | 2001-09-27 | Dsm N.V. | Talaromyces emersonii beta-glucanases |
| AU2001266978A1 (en) | 2000-06-14 | 2001-12-24 | Diversa Corporation | Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| US6423145B1 (en) | 2000-08-09 | 2002-07-23 | Midwest Research Institute | Dilute acid/metal salt hydrolysis of lignocellulosics |
| CA2422558C (en) | 2000-09-25 | 2012-02-14 | Iogen Energy Corporation | Method for glucose production with a modified cellulase mixture |
| US7256031B2 (en) * | 2000-09-29 | 2007-08-14 | Meiji Seika Kaisha, Ltd. | Enzyme having β-glucosidase activity and use thereof |
| WO2002029032A2 (en) | 2000-09-30 | 2002-04-11 | Diversa Corporation | Whole cell engineering by mutagenizing a substantial portion of a starting genome, combining mutations, and optionally repeating |
| JP2005501217A (ja) | 2000-10-10 | 2005-01-13 | ディベルサ コーポレーション | 生体活性または生体分子のハイスループットスクリーニングまたはキャピラリーに基づくスクリーニング |
| EP1332153A4 (en) | 2000-10-12 | 2006-01-11 | Exelixis Inc | HUMAN ECT2 AND METHOD OF USE THEREOF |
| US6309872B1 (en) | 2000-11-01 | 2001-10-30 | Novozymes Biotech, Inc | Polypeptides having glucoamylase activity and nucleic acids encoding same |
| EP1347770A4 (en) | 2000-11-30 | 2005-10-19 | Diversa Corp | PROCESS FOR PREPARING A PROTEIN POLYMER AND USE OF THE POLYMER |
| ES2521615T3 (es) | 2001-06-06 | 2014-11-13 | Novozymes A/S | Endo-beta-1,4-glucanasa |
| DK2295544T3 (da) | 2001-06-26 | 2016-09-26 | Novozymes As | Polypeptider med cellobiohydrolase I-aktivitet og polynukleotider, der koder for samme |
| US7393673B2 (en) | 2001-07-28 | 2008-07-01 | Midwest Research Institute | Thermal tolerant exoglucanase from Acidothermus cellulolyticus |
| WO2003012109A1 (en) | 2001-07-28 | 2003-02-13 | Midwest Research Institute | Thermal tolerant cellulase from acidothermus cellulolyticus |
| US6979733B2 (en) * | 2001-08-03 | 2005-12-27 | Diversa Corporation | Epoxide hydrolases, nucleic acids encoding them and methods of making and using them |
| EP1446495A4 (en) | 2001-10-01 | 2006-06-07 | Diversa Corp | ENTIRE CELL ENGINEERING USING REAL-TIME METABOLIC FLOW ANALYSIS |
| US7314974B2 (en) | 2002-02-21 | 2008-01-01 | Monsanto Technology, Llc | Expression of microbial proteins in plants for production of plants with improved properties |
| US6918738B2 (en) | 2002-03-11 | 2005-07-19 | Diversa Corporation | Stackable sample holding plate with robot removable lid |
| US20040005674A1 (en) | 2002-04-30 | 2004-01-08 | Athenix Corporation | Methods for enzymatic hydrolysis of lignocellulose |
| USD480814S1 (en) | 2002-06-11 | 2003-10-14 | Diversa Corporation | Gigamatrix holding tray |
| DK2305801T3 (da) | 2002-08-16 | 2017-10-09 | Danisco Us Inc | Hidtil ukendte hypocrea jecorina-cbh1-cellulaser |
| US6776979B2 (en) | 2002-12-30 | 2004-08-17 | Marvin B. Frager | Periodontal treatment compound and method of use |
| WO2004078919A2 (en) * | 2003-02-27 | 2004-09-16 | Midwest Research Institute | Superactive cellulase formulation using cellobiohydrolase-1 from penicillium funiculosum |
| US20040231060A1 (en) | 2003-03-07 | 2004-11-25 | Athenix Corporation | Methods to enhance the activity of lignocellulose-degrading enzymes |
| US7960148B2 (en) | 2003-07-02 | 2011-06-14 | Verenium Corporation | Glucanases, nucleic acids encoding them and methods for making and using them |
| EP1687419B1 (en) | 2003-10-28 | 2010-02-03 | Novozymes North America, Inc. | Hybrid enzymes |
| US7338763B2 (en) | 2004-06-02 | 2008-03-04 | Eppendorf Array Technologies S.A. | Method and kit for the detection and/or quantification of homologous nucleotide sequences on arrays |
| US20060147581A1 (en) | 2004-12-22 | 2006-07-06 | Novozymes A/S | Hybrid enzymes |
| WO2006096527A2 (en) * | 2005-03-04 | 2006-09-14 | Diversa Corporation | Nucleic acids and proteins and methods for making and using them |
| CA2611859C (en) | 2005-03-15 | 2015-03-31 | Verenium Corporation | Cellulases, nucleic acids encoding them and methods for making and using them |
| AU2007244753B2 (en) * | 2006-04-28 | 2012-05-17 | C5-6 Technologies, Inc. | Thermostable cellulase and methods of use |
| NZ598285A (en) * | 2007-01-30 | 2013-10-25 | Syngenta Participations Ag | Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| JP6449266B2 (ja) | 2013-06-21 | 2019-01-09 | バイオ−ラッド・ラボラトリーズ・インコーポレーテッド | 流体ピックアップを備えるマイクロ流体システム |
| KR102193685B1 (ko) | 2014-05-02 | 2020-12-21 | 삼성전자주식회사 | 수직 구조의 비휘발성 메모리 소자 |
-
2006
- 2006-12-08 NZ NZ59549706A patent/NZ595497A/xx not_active IP Right Cessation
- 2006-12-08 CN CN201310373730.1A patent/CN103555741A/zh active Pending
- 2006-12-08 EP EP20110007477 patent/EP2420570B1/en not_active Not-in-force
- 2006-12-08 WO PCT/US2006/046919 patent/WO2007094852A2/en not_active Ceased
- 2006-12-08 EP EP20110007478 patent/EP2444490B1/en not_active Not-in-force
- 2006-12-08 NZ NZ59549506A patent/NZ595495A/xx not_active IP Right Cessation
- 2006-12-08 AU AU2006338208A patent/AU2006338208B2/en not_active Ceased
- 2006-12-08 US US12/278,958 patent/US8101393B2/en not_active Expired - Fee Related
- 2006-12-08 CN CN201310373583.8A patent/CN103602692A/zh active Pending
- 2006-12-08 MY MYPI2012002364A patent/MY161027A/en unknown
- 2006-12-08 NZ NZ59550206A patent/NZ595502A/xx not_active IP Right Cessation
- 2006-12-08 EP EP20110007476 patent/EP2450439B1/en not_active Not-in-force
- 2006-12-08 EP EP20060845040 patent/EP1989301B1/en not_active Not-in-force
- 2006-12-08 DK DK11007476T patent/DK2450439T3/da active
- 2006-12-08 MY MYPI2012002360A patent/MY160772A/en unknown
- 2006-12-08 MY MYPI2012002357A patent/MY162321A/en unknown
- 2006-12-08 MY MYPI2012002358A patent/MY160770A/en unknown
- 2006-12-08 DK DK06845040T patent/DK1989301T3/da active
- 2006-12-08 MY MYPI2012002362A patent/MY160756A/en unknown
- 2006-12-08 NZ NZ59550006A patent/NZ595500A/xx not_active IP Right Cessation
- 2006-12-08 MY MYPI2012002361A patent/MY160710A/en unknown
- 2006-12-08 MY MYPI20083005A patent/MY147955A/en unknown
- 2006-12-08 EP EP20110007475 patent/EP2444489B1/en not_active Not-in-force
- 2006-12-08 NZ NZ59549806A patent/NZ595498A/xx not_active IP Right Cessation
- 2006-12-08 EP EP11007471.3A patent/EP2444487B1/en not_active Not-in-force
- 2006-12-08 EP EP20110007474 patent/EP2444488B1/en not_active Not-in-force
- 2006-12-08 NZ NZ571087A patent/NZ571087A/en not_active IP Right Cessation
- 2006-12-08 BR BRPI0621331-6A patent/BRPI0621331A2/pt not_active Application Discontinuation
- 2006-12-08 DK DK11007471.3T patent/DK2444487T3/da active
- 2006-12-08 DK DK11007477T patent/DK2420570T3/da active
- 2006-12-08 DK DK11007472T patent/DK2415864T3/da active
- 2006-12-08 NZ NZ59549906A patent/NZ595499A/xx not_active IP Right Cessation
- 2006-12-08 EP EP20110007472 patent/EP2415864B1/en not_active Not-in-force
- 2006-12-08 NZ NZ59550106A patent/NZ595501A/xx not_active IP Right Cessation
- 2006-12-08 MY MYPI2012002363A patent/MY161026A/en unknown
- 2006-12-08 EP EP20110007473 patent/EP2447363B1/en not_active Not-in-force
- 2006-12-08 CA CA 2637013 patent/CA2637013A1/en not_active Abandoned
- 2006-12-08 NZ NZ59549606A patent/NZ595496A/xx not_active IP Right Cessation
- 2006-12-08 CN CNA2006800541665A patent/CN101426909A/zh active Pending
-
2012
- 2012-01-20 US US13/354,503 patent/US9127263B2/en active Active
-
2013
- 2013-01-28 US US13/751,923 patent/US9175275B2/en active Active
-
2015
- 2015-10-23 US US14/921,954 patent/US20160108386A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2420570T3 (da) | Arabinofuranosidaseenzymer, nucleinsyrer, som koder for dem, og fremgangsmåder til at fremstille og anvende dem | |
| US8426184B2 (en) | Cellulases, nucleic acids encoding them and methods for making and using them | |
| AU2013205502B2 (en) | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |